Uncontrolled underlying of heart disease,
Conditions
Interventions
participants were patient with colorectal cancer receiving chemotherapy in a hospital setting (traditional chemotherapy administration),participants were patient with colorectal cancer receiving chemo
Health Services Research,Health Services Research
Inpatient group,ambulatory home chemotherapy group
Sponsors
Ramathibodi Hospital, Mahidol University
Eligibility
Sex/Gender
All
Age
20 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Colorectal cancer patient 2. Treatment: oxaliplatin/leucovirin/5-fluorouracil (mFOLFOX) and Irinotecan/leucovirin/5-fluorouracil (FOLFIRI) with 5-fluorouracil contrnuous infusion for 48-50 hours (both regimens) 3. Good ECOG performance status <3 4. Good compliance 5. Signed consent form
Exclusion criteria
Exclusion criteria: 1. Uncontrolled underlying disease 2. Cognitive impairment (it might be impacted of selfcare and device care at home)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health Related Quslity of Life (HRQLO) and adverse event December, 2015- November 2016 observational and comparative design | — |
Secondary
| Measure | Time frame |
|---|---|
| none none none | — |
Contacts
Public ContactSuwannee Sirilerttrakul
Ramathibodi Hospital, Mahidol University
Outcome results
None listed